GLENMEDE TRUST CO NA – Eli Lilly and Company Transaction History
GLENMEDE TRUST CO NA portfolio value:
$146.77M
portfolio value
GLENMEDE TRUST CO NA quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.80% | 12.36K shares | 3.60M | $323.35 | 453.92K |
| Q2 2022 | share | Decrease | -1.89% | -8.48K shares | 14.28M | $324.23 | 441.56K |
| Q1 2022 | share | Decrease | -8.81% | -43.47K shares | -7.44M | $286.37 | 450.05K |
| Q4 2021 | share | Decrease | -1.69% | -8.49K shares | 20.33M | $277.25 | 493.53K |
| Q3 2021 | share | Decrease | -1.60% | -8.17K shares | -1.10M | $230.3 | 502.02K |
| Q2 2021 | share | Decrease | -4.81% | -25.80K shares | 16.96M | $228.04 | 510.20K |
| Q1 2021 | share | Increase | +0.34% | 1.81K shares | 9.94M | $184.81 | 536.00K |
| Q4 2020 | share | Increase | +7.83% | 38.80K shares | 16.86M | $166.32 | 534.18K |
| Q3 2020 | share | Decrease | -1.30% | -6.52K shares | -9.07M | $145.05 | 495.37K |
| Q2 2020 | share | Decrease | -3.31% | -17.16K shares | 14.18M | $160.1 | 501.90K |
| Q1 2020 | share | 0.00% | 0 shares | 0 | $134.64 | 519.07K | |
| Q4 2019 | share | Decrease | -36.50% | -298.42K shares | -23.19M | $126.91 | 519.07K |
| Q3 2019 | share | Decrease | -7.81% | -69.21K shares | -6.81M | $107.36 | 817.49K |
| Q2 2019 | share | Decrease | -8.02% | -77.31K shares | -26.85M | $105.74 | 886.70K |
| Q1 2019 | share | Decrease | -12.82% | -141.72K shares | -2.86M | $123.17 | 964.01K |
| Q4 2018 | share | Increase | +2.08% | 22.55K shares | 11.71M | $109.26 | 1.10M |
| Q3 2018 | share | Decrease | -1.64% | -18.03K shares | 22.26M | $100.8 | 1.08M |
| Q2 2018 | share | Increase | +53.81% | 385.26K shares | 33.5M | $79.72 | 1.10M |
| Q1 2018 | share | 0.00% | 0 shares | 0 | $71.78 | 715.95K | |
| Q4 2017 | share | Decrease | -2.03% | -14.81K shares | -2.04M | $77.79 | 715.95K |
| Q3 2017 | share | Decrease | -2.36% | -17.67K shares | -442K | $78.29 | 730.76K |
| Q2 2017 | share | 0.00% | 0 shares | 0 | $74.85 | 748.44K | |
| Q1 2017 | share | Decrease | -16.04% | -142.95K shares | -2.61M | $76 | 748.44K |
| Q4 2016 | share | Decrease | -1.64% | -14.89K shares | -7.17M | $66.02 | 891.39K |
| Q3 2016 | share | Decrease | -2.27% | -21.08K shares | -293K | $71.57 | 906.29K |
| Q2 2016 | share | Increase | +2.21% | 20.09K shares | 7.69M | $69.79 | 927.37K |
| Q1 2016 | share | Increase | +3.53% | 30.96K shares | -8.50M | $63.39 | 907.28K |